SECsense Logo

MEDIROM Healthcare Financial Report: February 2025 Insights & Preliminary Results

$MRM
Form 6-K
Filed on: 2025-02-18
Source
MEDIROM Healthcare Financial Report: February 2025 Insights & Preliminary Results

Here's a summary of the key information extracted from the financial report of MEDIROM Healthcare Technologies Inc. dated February 18, 2025:

Company Overview

  • Name: MEDIROM Healthcare Technologies Inc.
  • Location: 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.
  • SEC File Number: 001-39809.

Report Type

  • Form: 6-K - Report of Foreign Private Issuer.
  • Reporting Period: For the month of February 2025.

Financial Information

  • Issuance of Press Release: The company issued a press release detailing unaudited, preliminary financial results for the year ended December 31, 2024.
  • Preparation Standards: The results are prepared in accordance with Japanese generally accepted accounting principles, with one adjustment noted in the press release, and are not reviewed or audited under U.S. GAAP.
  • Caution on Reliability: The preliminary financial results are subject to various adjustments and may differ from the final audited results. Investors are cautioned not to rely on this preliminary information as it has not been finalized.

Forward-Looking Statements

  • The report includes forward-looking statements that are subject to risks and uncertainties. Actual results may vary significantly from those projected. Key terms indicating such statements include "expect," "estimate," "project," "anticipate," etc.
  • Risks associated are discussed in the company's previous filings, particularly in the Annual Report on Form 20-F.

Important Notices

  • The information in this Form 6-K is not to be deemed "filed" for the purposes of the Securities Exchange Act of 1934 and thus is not subject to liabilities under that section.

Signatures

  • Date: February 18, 2025.
  • Authorized Signatory: Fumitoshi Fujiwara, Chief Financial Officer.

Exhibit

  • Exhibit 99.1: Contains the press release dated February 18, 2025, providing more detailed financial results.

This summary captures the essential aspects of the report, highlighting the company's financial disclosure, cautionary statements regarding the reliability of the information provided, and relevant details about its SEC filing.